{"id":"NCT03139604","sponsor":"Incyte Corporation","briefTitle":"GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease","officialTitle":"GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-19","primaryCompletion":"2019-05-02","completion":"2020-07-13","firstPosted":"2017-05-04","resultsPosted":"2020-05-15","lastUpdate":"2025-09-02"},"enrollment":439,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Graft-versus-host Disease (GVHD)"],"interventions":[{"type":"DRUG","name":"Itacitinib","otherNames":["INCB039110"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Prednisone","otherNames":["Deltasone","Prednicot","predniSONE Intensol","Rayos","Sterapred","Sterapred DS"]},{"type":"DRUG","name":"Methylprednisolone","otherNames":["Medrol","Medrol Dosepak","Solu-Medrol"]}],"arms":[{"label":"Itacitinib","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).","primaryOutcome":{"measure":"Overall Response Rate Based on Center for International Blood and Marrow Transplant Research (CIBMTR) Response Index","timeFrame":"Day 28","effectByArm":[{"arm":"Itacitinib Plus Corticosteroids","deltaMin":74,"sd":null},{"arm":"Placebo Plus Corticosteroids","deltaMin":66.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0782"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":14},"locations":{"siteCount":129,"countries":["United States","Australia","Austria","Belgium","Czechia","Finland","France","Germany","Greece","Israel","Italy","New Zealand","Poland","Portugal","South Korea","Spain","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["35689489","34971577"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":133,"n":215},"commonTop":["Thrombocytopenia","Anaemia","Oedema peripheral","Hyperglycaemia","Diarrhoea"]}}